 |
Partnerships |
|
|
|
|
|
|
|
Strategic Alliance with PricewaterhouseCoopers
Expert scientific knowledge and commercial experience are critical when deciding which R&D programs or life science companies to invest in or which licensing or acquisition opportunity to pursue. Using the peer review process common to the research community, evalueSCIENCE’s input will complement PwC's expertise in the Life Sciences industry with deep scientific knowledge.
evalueSCIENCE and PwC offer their joint intelligence to address challenges in:
• Due diligence – get a complete view of the risks and true innovation potential of research projects, technologies and investment opportunities
• Strategy development – identify competitive advantages and threats from both scientific and market perspectives
• Science and technology forecasting – access and structure the knowledge of key opinion leaders to recognize emerging trends
• Assessments – obtain more accurate asset valuations through scientific peer review as well as commercial market and competitor strategy assessments
• Portfolio review – uncover the hidden potential of assets and develop your business strategy to include them
| |
|
|
|
|
Cooperation with Bridge4Bio
evalueSCIENCE collaborates with Bridge4Bio, a San Francisco based international business consultancy group focused on promoting the growth of life science companies in the areas of channel development, strategic marketing, global souring and capital investment. Bridge4Bio covers academic research, drug discovery, pharmaceuticals, biotechnology, medical devices and healthcare. Bridge4Bio's capabilities extend beyond its core senior consultants and draws on the expertise of advisors working in major biotechnology and life science growth markets worldwide.
| |
|
